Catalog No.S5676 Synonyms: F2 toxin, RAL

For research use only.

Zearalenone (F2 toxin, RAL) is a non-steroidal estrogenic mycotoxin that acts by binding the estrogen receptor (ER).

Zearalenone Chemical Structure

CAS No. 17924-92-4

Selleck's Zearalenone has been cited by 1 Publication

Purity & Quality Control

Choose Selective Estrogen/progestogen Receptor Inhibitors

Other Estrogen/progestogen Receptor Products

Biological Activity

Description Zearalenone (F2 toxin, RAL) is a non-steroidal estrogenic mycotoxin that acts by binding the estrogen receptor (ER).
ERβ [1] ERα [1]
165.7 nM 240.4 nM
In vitro

Zearalenone is able to occupy the active site of ERs in a strikingly similar manner as E2[1]. Zearalenone disrupts genome stability and inhibits growth of porcine granulosa cells via the estrogen receptors which may promote granulosa cell apoptosis when the DNA repair system is not enough to rescue this serious damage[3]. At low concentrations, ZEN enhances cell proliferation, increases colony formation and fastens cell migration after wound healing. Zearalenone exhibits carcinogenesis-like properties[4].

In vivo In ovariectomized female ICR mice, s.c. administration of ZEN at doses ≥2 mg/kg/day for 3 consecutive days significantly increased uterine wet weight compared with the control group[1]. Zearalenone is an immunotoxic compound similar to estrogen and some endocrine disruptors. After oral exposure, ZEA is rapidly absorbed and initially metabolized by the intestinal tissue and hepatocytes; this initiates the biotransformation of the compound into its major biologically active reductive metabolites, α- and β-zearalenol (α- and β-ZOL). The estrogenic activity of ZEA and its metabolites is mediated by their binding affinity to estrogen receptors (ER), and they are as potent as coumestrol and genistein, two endocrine-disrupting phytestrogens[2].

Protocol (from reference)

Cell Research:


  • Cell lines: HCT116 cells
  • Concentrations: 0-320 μM
  • Incubation Time: 48 h
  • Method:

    Human colon carcinoma cells (HCT116) were maintained as monolayer culture in DMEM, supplemented with 10 % fetal bovine serum (FBS), 1 % l-glutamine (200 mM), 1 % of mixture penicillin (100 IU/ml) and streptomycin (100 μg/ml), in a humidified incubator at 37°C in an atmosphere of 5 % CO2 in air. ZEN is dissolved in pure ethanol. Cell viability was assessed using the methylene blue staining assay. Approximately 20,000 cells per well were seeded in 96-well plates with increasing ZEN or AFB1 concentrations (0-320 μM) at 37°C for 48 h in a final volume of 200 μl. The medium was then removed and cells were gently washed twice with PBS (1x), fixed with 3 % PFA for 5 min at room temperature then stained for 5 min with 0.1 % methylene blue. After extensive washing in water, methylene blue was eluted from cells using 0.1 % HCl, and the absorption of the supernatants was measured at 590 nm in a fluorimiter plate reader.

Animal Research:


  • Animal Models: ovariectomized ICR mice
  • Dosages: 0.5-100 mg/kg/day
  • Administration: s.c.

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 318.36


CAS No. 17924-92-4
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC1CCCC(=O)CCCC=CC2=C(C(=CC(=C2)O)O)C(=O)O1

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04687176 Recruiting Drug: Oral Arsenic Trioxide Formulation Acute Promyelocytic Leukemia The University of Hong Kong January 1 2021 Phase 2

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Zearalenone | Zearalenone supplier | purchase Zearalenone | Zearalenone cost | Zearalenone manufacturer | order Zearalenone | Zearalenone distributor